USD 0.0
(-50.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 77.04 Thousand USD | -84.71% |
2022 | 503.9 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | - USD | 100.0% |
2024 Q3 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q2 | 74.02 Thousand USD | 0.0% |
2023 FY | 77.04 Thousand USD | -84.71% |
2023 Q4 | -1.55 Million USD | -51589.43% |
2023 Q3 | 3017.00 USD | -95.92% |
2023 Q1 | - USD | -100.0% |
2022 Q4 | 320.27 Thousand USD | 74.42% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q3 | 183.62 Thousand USD | 0.0% |
2022 FY | 503.9 Thousand USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Acutus Medical, Inc. | 7.16 Million USD | 98.925% |
Biotricity, Inc. | 12.06 Million USD | 99.361% |
Cell MedX Corp. | - USD | -Infinity% |
Dynatronics Corporation | 32.53 Million USD | 99.763% |
PetVivo Holdings, Inc. | 968.7 Thousand USD | 92.047% |
RetinalGenix Technologies Inc. | - USD | -Infinity% |
Sonendo, Inc. | 43.86 Million USD | 99.824% |
Telesis Bio, Inc. | 27.5 Million USD | 99.72% |
Talis Biomedical Corporation | 412 Thousand USD | 81.3% |
Viveve Medical, Inc. | 6.42 Million USD | 98.801% |